AF
CRMD icon

Amalgamated Financial’s CorMedix CRMD Stock Holding History

Amalgamated Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$26K Buy
+4,747
New +$21.7K ﹤0.01% 2658

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Financial's CRMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in CorMedix (CRMD) in Q1 2022: 4,747 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #2658 among its holdings.

85 funds tracked by Wall St. Rank hold CRMD as of Q1 2022.

  • Amalgamated Financial held 4,747 shares of CorMedix worth $26K as of Q1 2022.
  • CorMedix was a new Amalgamated Financial position in Q1 2022.
  • CorMedix made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2658 holding.
  • 85 funds tracked by Wall St. Rank held CorMedix as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.